WP
IMUX icon

Woodline Partners’s Immunic IMUX Stock Holding History

Woodline Partners’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.25M Buy
471,528
+374,813
+388% +$4.62M 0.02% 604
2026
Q1 		$1.07M Buy
+96,715
New +$866K ﹤0.01% 879
2024
Q4 		– Sell
-11,865
Closed -$196K – 964
2024
Q3 		$196K Buy
+11,865
New +$169K ﹤0.01% 577

Other funds holding IMUX

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return

Woodline Partners's IMUX Position: Q2 2026 in Review

Woodline Partners increased its Immunic (IMUX) stake by 388% in Q2 2026, buying an estimated $4.62M and bringing the position to 471,528 shares worth $7.25M. The position accounts for 0.02% of the portfolio, ranked #604.

Woodline Partners first reported a position in IMUX in Q3 2024 and has held it in 3 quarters since. 55 funds tracked by Wall St. Rank hold IMUX as of Q2 2026.

  • Woodline Partners held 471,528 shares of Immunic worth $7.25M as of Q2 2026.
  • Woodline Partners bought 374,813 Immunic shares in Q2 2026, an estimated $4.62M.
  • Immunic made up 0.02% of Woodline Partners's portfolio in Q2 2026, its #604 holding.
  • Woodline Partners first reported a position in Immunic in Q3 2024 and has held it in 3 quarters since.
  • 55 funds tracked by Wall St. Rank held Immunic as of Q2 2026.

Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.